Today in Peak History (November 1-20)
Release time:
2020-08-14
peak history (11# March 1 - 20 )
1982 11 , Jinhua cement plant invested 60 yuan to rebuild the second vertical kiln and end the production history of Puli kiln.
◆ 1991 November 23, then chairman and general manager du Zihong was named a national model worker in the building materials industry.
In the first ten days of 1993 , the trade union of Jianfeng Group Company was awarded the title of "Advanced Unit for National Workers' Representative Work. ◆ 1994
11 July 16 , at the bankruptcy auction of Jinhua MSG Factory held by Jinhua Intermediate People's Court, Jianfeng Group Company bought all the property rights of Jinhua MSG Factory at a bid of 1400 yuan, ranking first among medium-sized state-owned enterprises in Zhejiang Province. ◆ 1997
11 August 4 , Zhejiang Administration for Industry and Commerce recognized the "Peak" brand cement trademark as a provincial famous trademark. ◆ 2010
11 3 , spike pharmaceutical "aspartate amlodipine series salt and its preparation method and its composition, preparation and tablet" won the invention patent certificate, the patent term is 20 years. ◆ 2011
11 , daye peak was named the first batch of leading enterprise brands in the national cement market, and "peak brand" cement was awarded the title of "Hubei famous brand product. ◆ 2014
11 , daye peak cement company was awarded the title of "2013-2014 building materials industry management system certification outstanding enterprise. ◆ 2015
11# In August, Peak became the second batch of "three" cultivation pilot enterprises in Zhejiang Province. ◆ 2016
◆ 2017 November
◆ On November 1, 102, 101, 2017 , July 105, the key product of Jianfeng Pharmaceutical, Lestat (Amlodipine Aspartate Tablets) was named "2017
National Medical Economic Information Conference ". ◆ 2008 # November# November , CCTV's "Passivity Square" column sang the 50th anniversary celebration of peak entrepreneurship. Vice Governor Jin Deshui, China Cement Association, China Pharmaceutical Association and other leaders and relevant units sent congratulatory messages to express their congratulations. Mayor Chen Kunzhong delivered a speech at the celebration on behalf of Jinhua Municipal Committee and Municipal Government. (Xu Xia finishing)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page